PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyJoanne I. Hsu, Margaret A. Goodell, Jianhua Zhang et al.|Cell stem cell|2018Cited by 423
Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasmsAdam S. Sperling, Koichi Takahashi, Veronica Guerra et al.|Blood|2022Cited by 138
Comprehensive Analysis of Genotype and Prior Exposures in Therapy-Related Myeloid Neoplasms (t-MNs)Veronica Guerra, Koichi Takahashi, Yuanqing Yan et al.|Blood|2019Cited by 8